---
title: 'Senior Manager / Associate Director, Medical Information at BridgeBio Pharma'
canonical: 'https://feeny.ai/job/senior-manager-associate-director-medical-information-bridgebio-pharma-united-43ankxcabebt'
type: 'job'
last_seen: '2026-10-28'
---

# Senior Manager / Associate Director, Medical Information at BridgeBio Pharma

- **Company:** BridgeBio Pharma
- **Location:** United States
- **Compensation:** $165k–$210k
- **Work type:** remote
- **Posted:** 2026-10-27
- **Last confirmed live:** 2026-10-28
- **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5274390007

## Job description

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on

In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.

Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

## What You’ll Do

The Senior Manager/Associate Director, Medical Information will support the execution of the Medical Information function for the BridgeBio Skeletal Dysplasia program, infigratinib. Reporting to the Director, Medical Information, this role will serve as a hands-on content and operational lead, responsible for the development, review, and maintenance of high-quality, accurate, and compliant medical information delivered to internal and external stakeholders.

This individual will work closely with the Director, Medical Information, Medical Affairs, Clinical Development, Regulatory, Pharmacovigilance, Commercial, and external vendors to ensure consistent, high-quality scientific exchange, while tailoring medical information content and processes to the condition, stage of development, and stakeholder needs.

## Responsibilities

- Support the development and execution of the Medical Information strategy for infigratinib, aligned with overall Medical Affairs and program objectives
- Serve as a subject matter expert and day-to-day Medical Information lead for infigratinib, maintaining deep knowledge of the condition, product, and competitive landscape
- Author, review, and maintain Medical Information materials, including standard response letters, FAQs, and custom response letters for escalated inquiries
- Ensure scientific accuracy, medical rigor, and consistency of content, and ensure Medical Information activities comply with applicable regulations, company policies, and industry standards
- Conduct ongoing literature surveillance and partner with Clinical and Translational teams to ensure incorporation of the latest data and insights
- Implement and help refine SOPs, workflows, and quality controls for intake, response, documentation, and reporting of Medical Information inquiries
- Partner closely with Pharmacovigilance to ensure appropriate adverse event and product complaint reporting
- Support the management of external Medical Information vendors, including scope definition, training, quality review of inquiry handling, and performance metrics
- Oversee day-to-day intake and response to unsolicited medical inquiries from healthcare professionals, patients, and other stakeholders
- Serve as Medical Information representative on medical, legal, and regulatory (MLR) review committees, as appropriate, and support Medical Information presence at scientific congresses
- Collaborate with Field Medical, Publications, Commercial, and Patient Advocacy teams to ensure aligned scientific messaging and a seamless stakeholder experience
- Support scientific communication activities in partnership with Medical Affairs and Publications
- Analyze and report inquiry metrics and trends, and present insights to inform medical strategy, evidence generation, and educational initiatives
- Contribute to the evaluation and implementation of tools and technologies, including AI-enabled solutions, that improve the efficiency and quality of Medical Information processes
- Support readiness activities for new data, indications, and lifecycle milestones, including the development of timely Medical Information resources

Where You’ll Work

This is a U.S.-based remote role that may require quarterly, or as needed, visits to our San Francisco Office or other locations for key internal meetings.

## Who You Are

- Advanced degree required (MD, PharmD, PhD, or equivalent scientific degree)
- 3+ years (Senior Manager) or 5+ years (Associate Director) of experience in Medical Information and/or Medical Affairs within biotechnology or pharmaceutical settings; completion of a Medical Information or Medical Affairs fellowship will also be considered for the Senior Manager level
- Demonstrated experience developing high-quality Medical Information content, including standard and custom response letters and FAQs
- Experience supporting Medical Information operations, including vendor oversight and inquiry quality review
- Experience in rare disease preferred
- Working knowledge of Medical Information compliance, regulations, and industry best practices, including medical review processes
- Strong written and verbal communication skills, with the ability to translate complex clinical data into clear, balanced responses
- Strong cross-functional collaboration skills and ability to operate effectively in a fast-paced, matrixed, and evolving organization
- Prior experience in a lean, growing biotech environment preferred
- High level of scientific curiosity, attention to detail, and commitment to patient-focused medical excellence

At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states.

Salary $165,000—$210,000 USD

As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

For BridgeBio Full-Time U.S Based Roles:

Financial & Rewards

- Market-leading compensation
- 401(k) with employer match
- Employee Stock Purchase Program (ESPP)
- Pre-tax commuter benefits (transit and parking)
- Referral bonus for hired candidates
- Subsidized lunch and parking on in-office days

Health & Well-Being

- 100% employer-paid medical, dental, and vision premiums for you and your dependents
- Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA)
- Fertility & family-forming benefits
- Expanded mental health support (therapy and coaching resources)
- Hybrid work model with flexibility
- Flexible, “take-what-you-need” paid time off and company-paid holidays
- Comprehensive paid medical and parental leave to care for yourself and your family

Skill Development & Career Paths:

- People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
- We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching
- We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

By applying, you acknowledge that BridgeBio will process your personal information as described in our [Global Candidate Privacy Notice](https://bridgebio.com/bridgebio-global-candidate-privacy-notice).

## About BridgeBio Pharma

## Company Overview
- **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization.
- **Entity Type**: Public (Nasdaq: BBIO)
- **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA)
- **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016.
- **Founders**: Not publicly available from provided sources.

## Core Business
- **Primary industry**: Biotechnology / Genetic disease therapeutics
- **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners
- **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.”

## Products & Services
BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings:

- **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential.
- **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026).
- **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9).
- **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1).
- **BBP-812**: Investigational for Canavan Disease.
- **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers.
- **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology.
- **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more.

The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**.

## Market Standing
- **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number).
- **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years.
- **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research.
- **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted.

## Competitive Advantages
- **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction.
- **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale.
- **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech.
- **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions.

## Strategic Focus
- **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals.
- **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers.
- **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster.
- **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach.

## Why Work Here
- **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025.
- **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized.
- **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility.
- **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra.
- **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.”
- **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles.

## Sources
1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential
2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics
3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits
4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation
5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories

## Other roles at BridgeBio Pharma

- [Senior Marketing Manager, Skeletal Dysplasia](https://feeny.ai/job/senior-marketing-manager-skeletal-dysplasia-bridgebio-pharma-san-francisco-sdpr3bac78fx) — San Francisco, CA / Palo Alto, CA
- [Senior Field Medical Director, Strategic Operations](https://feeny.ai/job/senior-field-medical-director-strategic-operations-bridgebio-pharma-san-4150ptsdsp16) — San Francisco, CA
- [BD&Ops Director / Sr. Director](https://feeny.ai/job/bd-ops-director-sr-director-bridgebio-pharma-palo-alto-ffv4vme42c72) — Palo Alto, CA
- [Field Reimbursement Manager, Southwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-southwest-skeletal-dysplasia-bridgebio-pharma-fay16wzevn61) — United States
- [Field Reimbursement Manager, Southeast - Skeletal Dysplasia,](https://feeny.ai/job/field-reimbursement-manager-southeast-skeletal-dysplasia-bridgebio-pharma-fxt0f3sdwdn4) — United States
- [Field Reimbursement Manager, Midwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-midwest-skeletal-dysplasia-bridgebio-pharma-united-b7mx2yyg45rj) — United States
- [Director, Field Reimbursement - East](https://feeny.ai/job/director-field-reimbursement-east-bridgebio-pharma-united-states-rbt720p8m8g3) — United States
- [Director, Government Pricing & Contract Operations](https://feeny.ai/job/director-government-pricing-contract-operations-bridgebio-pharma-san-francisco-3drkp53atz53) — /san Francisco CA & Palo Alto, CA
- [Senior Manager, Corporate Communications](https://feeny.ai/job/senior-manager-corporate-communications-bridgebio-pharma-palo-alto-95nq7sks6gtc) — Palo Alto, CA
- [Director, Managed Markets - Regional - Northeast](https://feeny.ai/job/director-managed-markets-regional-northeast-bridgebio-pharma-united-states-dfmav26y6zg3) — United States